Plerixafor for Stem Cell Mobilization in Allogeneic Stem Cell Donors

被引:0
|
作者
Overman, Bethany Janette [1 ]
McNiece, Ian [2 ]
Mercado, Greg [3 ]
Slipall, Elizabeth J. [2 ]
Hosing, Chitra [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplant & Cellular Therapy, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Pheresis, Houston, TX 77030 USA
关键词
D O I
10.1016/j.bbmt.2015.11.1082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
745
引用
收藏
页码:S472 / S472
页数:1
相关论文
共 50 条
  • [1] Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update
    Bilgin, Yavuz M.
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 403 - 412
  • [2] Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
    Schroeder, Mark A.
    Rettig, Michael P.
    Lopez, Sandra
    Christ, Stephanie
    Fiala, Mark
    Eades, William
    Mir, Fazia A.
    Shao, Jin
    McFarland, Kyle
    Trinkaus, Kathryn
    Shannon, William
    Deych, Elena
    Yu, Jinsheng
    Vij, Ravi
    Stockerl-Goldstein, Keith
    Cashen, Amanda F.
    Uy, Geoffrey L.
    Abboud, Camille N.
    Westervelt, Peter
    DiPersio, John F.
    BLOOD, 2017, 129 (19) : 2680 - 2692
  • [3] Addition of plerixafor in poorly mobilized allogeneic stem cell donors
    Zhuang, Lefan
    Lauro, Deisen
    Wang, Shirong
    Yuan, Shan
    JOURNAL OF CLINICAL APHERESIS, 2022, 37 (04) : 388 - 394
  • [4] EFFICACY OF PLERIXAFOR IN CD34+ STEM CELL MOBILIZATION IN HEALTHY PEDIATRIC STEM CELL DONORS
    Bharadwaj, Rishab
    Kumar, Vimal
    Munirathnam, Deenadayalan
    BONE MARROW TRANSPLANTATION, 2024, 59 : 644 - 644
  • [5] Addition of Plerixafor in Poorly Mobilized Allogeneic Hematopoietic Stem Cell Donors
    Zhuang, Lefan
    Boriboonnangkul, Pudpong
    Wang, Shirong
    Yuan, Shan
    TRANSFUSION, 2018, 58 : 71A - 72A
  • [6] Scoping Review of Factors Associated with Stem Cell Mobilization and Collection in Allogeneic Stem Cell Donors
    Peck, Rachel C.
    Knapp-Wilson, Amber
    Burley, Kate
    Doree, Carolyn
    Griffin, James
    Mumford, Andrew D.
    Stanworth, Simon
    Sharplin, Kirsty
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (09): : 844 - 863
  • [7] PLERIXAFOR ON DEMNAD IN FIVE HEALTHY FAMILY DONORS TO MOBILIZATION FOR STEM CELL TRANSPLANTATION
    Pradillo Fernandez, Virginia
    Pascual, Cristina
    Perez-Corral, Ana
    Serrano, David
    Dorado, Nieves
    Solan, Laura
    Kwon, Mi
    Diez Martin, Jose Luis
    Anguita, Javier
    BONE MARROW TRANSPLANTATION, 2018, 53 : 781 - 782
  • [8] Stem cell mobilization with plerixafor has advantages
    Krome, Susanne
    TRANSFUSIONSMEDIZIN, 2025, 15 (01) : 7 - 7
  • [9] Autologous Stem Cell Mobilization in the Age of Plerixafor
    Cooper, Dennis L.
    Medoff, Erin
    Patel, Natalie
    Baker, Julie
    Pratt, Kathryn
    Foss, Francine
    Seropian, Stuart E.
    Perreault, Sarah
    Wu, Yanyun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (07): : 411 - 416
  • [10] Economic Evaluation of Plerixafor for Stem Cell Mobilization
    Kymes, Steven M.
    Pusic, Iskra
    Lambert, Dennis L.
    Gregory, Martin
    Carson, Kenneth R.
    DiPersio, John F.
    AMERICAN JOURNAL OF MANAGED CARE, 2012, 18 (01): : 33 - 41